NCT06669169

Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure

A Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical Trial：Efficacy and Safety of Jia Shen Tablets in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Yang Qi Deficiency With Blood Stasis)

• Status: Not Yet Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 288 (estimated)
• Sponsor: Tasly Pharmaceutical Group Co., Ltd · Industry
• Sex: All
• Age: 40 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

Evaluate the efficacy and safety of Jia Shen Tablets in patients with Chronic Heart Failure.

Conditions

• Heart Failure

Interventions

Type	Name	Description
DRUG	Jia Shen Tablet Placebo	Jia Shen Tablet Placebo contains 4 placebo tablets (0.47 g per placebo tablet),take orally, 2 times a day for 12 weeks
DRUG	Low dose Jia Shen Tablet	Low dose Jia Shen Tablet contains 2 tablets (0.47 g per tablet) and 2 placebo tablets (0.47 g per placebo tablet),take orally, 2 times a day for 12 weeks
DRUG	High dose Jia Shen Tablet	High dose Jia Shen Tablet contains 4 tablets (0.47 g per tablet),take orally, 2 times a day for 12 weeks

Timeline

• Start date: 2025-01-31
• Primary completion: 2026-12-31
• Completion: 2026-12-31
• First posted: 2024-11-01
• Last updated: 2024-11-01

Locations

1 site across 1 country: China